BEZLOTOXUMAB

Search structure
Trade Names:
Synonyms:
Status: Approved (2016)
Entry Type: Antibody
Molecule Category: UNKNOWN
ATC: J06BB21
UNII: 4H5YMK1H2E

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Toxin B inhibitor FDA

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Clostridium Infections 4 D003015 ClinicalTrials

Adverse Reactions

SOC By Demographic Distribution
System Organ Classification (SOC)
Relative Frequency (%)
General disorders and administration site conditions
26.74
Infections and infestations
13.55
Gastrointestinal disorders
8.79
Respiratory, thoracic and mediastinal disorders
7.69
Cardiac disorders
7.33
Injury, poisoning and procedural complications
4.76
Vascular disorders
4.76
Investigations
4.4
Nervous system disorders
4.4
Musculoskeletal and connective tissue disorders
2.93
Surgical and medical procedures
2.93
Metabolism and nutrition disorders
2.56
Psychiatric disorders
2.56

Cross References

Resources Reference
CAS NUMBER 1246264-45-8
ChEMBL CHEMBL2108670
FDA SRS 4H5YMK1H2E
CONTENTS